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Preterm infantThe importance of early life events in the development of metabolic diseases is well recognized. Early post-
natal environment, including nutrition, is key to future health, and this is particularly true for preterm infants.
It is important that these infants receive sufficient nutrients to prevent growth restriction and promote neu-
rodevelopment, while minimizing predisposition to metabolic diseases later in life. Feeding habits are the
fundamental elements of nutrition and are influenced by many factors, including personal and familial habits,
socioeconomic status, and cultural environment. In the last decades, there has been an important scientific
interest toward the comprehension of the molecular and neural mechanisms regulating appetite. In these
networks, act many peptide hormones produced in brain or gut, among which ghrelin is important because
of its action in the short-term regulation of food intake and the long-term regulation of body weight. Ghrelin
stimulates appetite and plays a role in regulating feeding behaviour. Ghrelin levels vary from fetal life
through to early adulthood, with the highest levels observed in the very early years. Cord ghrelin levels
have been evaluated in term and preterm newborns and high ghrelin levels have been observed in small-
for-gestational age newborns and in newborns with intrauterine growth restriction. Moreover, ghrelin has
been detected in term and preterm human breast milk, suggesting that it may play a role in the development
of neuroendocrine pathways regulating appetite and energy homeostasis in early life. However, more re-
search is required to better define ghrelin's role in breast milk and on feeding behaviour.
© 2011 Elsevier Ltd. All rights reserved.1. Introduction
Feeding behaviour is a complex interaction of physiological, psy-
chological, social, and genetic factors that influence meal quantity,
frequency and timing, and food choices. Studying the biological
mechanisms guiding feeding behaviour is important for understand-
ing the pathophysiology of obesity, as food intake is a significant fac-
tor impacting the development and treatment of this disorder and its
associated comorbidities [1].
Feeding habits are the fundamental elements of nutrition, and are
influenced by many factors, including personal and familial habits, so-
cioeconomic status, and cultural environment. Feeding is a primary
event in the life of an infant, and early feeding experiences affect
both health and psychological well-being, setting the stage for
healthy feeding-associated behaviours in childhood and adulthood.
Proper nutrition in early infancy is essential for normal growth
and may have a substantial impact on long-term health and optimal
neurological and cognitive development [2]. Also the length of, Regina Margherita Children's
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health and survival. In the last 20 years, significant progress has
been made in the quality of care provided to preterm infants, with
particular attention being paid to their nutrition in order to achieve
proper growth [3].
Growth in infancy is related to nutritional intake and therefore po-
tentially to the circulating levels of hormones such as ghrelin, insulin,
and leptin. In particular, ghrelin, a hormone primarily produced by
the stomach and pancreas, is involved in the neuroregulation of appe-
tite and feeding behaviour, promoting meal intake and hunger, and
contributing to obesity risk by increasing caloric intake. The study of
this hormone and its genetic variants can provide new insights into
the understanding of the mechanisms of eating behaviour [4].
Behavioural research in infant feeding has focused on breastfeed-
ing showing that it has beneficial effects on infant-feeding style, im-
proving infant's ability to self-regulate appropriate food intake and
contributing to healthier eating patterns [5]. The recent identification
in breast milk (BM) of adipokines and other hormones, such as ghre-
lin, involved in energy-balance regulation suggests that BM may
modulate neuroendocrine pathways involved in the regulation of ap-
petite and feeding behaviour [6,7]. Diet-related differences during in-
fancy in serum levels of factors involved in energy metabolism might
explain anthropometric differences and differences in dietary habits
between breast-fed (BF) and formula-fed (FF) infants also later inaviour in preterm infants, Early Hum Dev (2012), doi:10.1016/
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on the development of obesity [8].
2. Importance of feeding in the first periods of life: the preterm
infant
The first years of life are particularly important because a child's
feeding abilities and needs change with motor, cognitive, and social
development. In the first 3 months of life, the infant integrates expe-
riences of hunger and satiety to develop regular feeding patterns. Af-
terwards, the infant forms an attachment with the primary caregiver
and parents' behaviours influence the infant's feeding experience.
From the sixth month of life, the infant gradually discovers a sense
of autonomy, using motor and language skills to control the environ-
ment and establish self-regulation feeding [9]. These stages in the de-
velopment of feeding behaviour are fundamental for infant growth.
Achieving appropriate growth and nutrient accretion is particular-
ly important and often difficult for preterm infants, because of their
special needs, as a result of metabolic and gastrointestinal immaturi-
ty, compromised immune function, and other complicating medical
conditions. For preterm infants, these problems include immaturity
of bowel function, inability to suck and swallow, high risk of necrotiz-
ing enterocolitis, illnesses that may interfere with adequate enteral
feeding, and medical interventions that preclude feeding. In fact, pre-
term neonates are subject to physiological and metabolic stress that
can affect their nutritional needs, such as respiratory distress or infec-
tions. Moreover preterm infants, especially those who have been
growth restricted in utero, have fewer nutrient reserves at birth
than term infants. Thus, multiple problems regarding premature in-
fants may affect nutritional issues.
Particularly, preterm birth interrupts gut maturation and the devel-
opment of gastrointestinal (GI) functions and feeding abilities. In fetal
life, gut has formed by 10 weeks of gestation. By 16 weeks, the fetus
can swallow amniotic fluid: it contains carbohydrates, protein, fat, elec-
trolytes, immunoglobulins, and growth factors, and plays an important
role in the development of GI functions. GI motor activity is present be-
fore 24weeks, but organized peristalsis is not established until 29 or 30
weeks, and coordinated sucking and swallowing develops at 32–34
weeks [10]. Preterm birth interrupts all of these processes.
In the last 20 years, significant progress has been made in the
quality of care provided to preterm infants. During this period, studies
on neonatal nutrition have produced important results looking for the
optimal feeding policy to achieve proper growth in these infants.
However, a disparity in nutritional practice and feeding strategies in
neonatal units has been noticed. Indeed, most investigations of nutri-
ent metabolism over the past two decades have reached conflicting
conclusions. Most of the research showed analysis of observational
data and was conducted on heterogeneous populations with conse-
quent limitations.
The goal of nutrition in preterm infants is to attempt to optimize
growth and neurodevelopmental outcomes, avoiding short-term
and long-term adverse outcomes. There is increasing evidence that
the nutrition of the appropriate-for-gestational age (AGA) versus in-
trauterine growth-restricted infants may need to be different, given
the differences in growth in intrauterine life and in metabolic homeo-
stasis. The identification of infants that have suffered growth failure
in utero has become of primary importance. A single marker for al-
tered metabolism in infants with intrauterine growth restriction
(IUGR) has not yet been detected. Recent studies have focused on in-
dices of fetal blood sampling (e.g. acidosis), abnormal fetal blood flow
indices, cortisol and leptin levels in cord or neonatal blood, and mod-
ified insulin sensitivity testing [11-13].
The American Academy of Pediatrics has proposed some specific
nutrient requirements for preterm infants distinct from those for
term infants. Nutrient amounts recommended for preterm infants
must be sufficient to allow growth similar to that achieved by termPlease cite this article as: Savino F, et al, Ghrelin and feeding beh
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are also born small-for-gestational age (SGA), so there is an additional
need for enough catch-up growth to bring them to the size of a nor-
mal fetus of comparable gestational age. Nevertheless, the question
emerges of whether a growth rate of 15 g/(kg · d), which has been
used as a minimum growth standard, is adequate. Neonatal undernu-
trition is a risk to physical and mental development. On the other
hand, overfeeding could also be harmful.
Furthermore, an important nutritional issue is the need to deter-
mine how the composition of formula affects the composition of
weight gained, particularly whether there is an optimum energy-to-
protein ratio above which an increase in energy intake would result
in mainly fat storage.
On the basis of studies of the effects of diet on composition of
weight gain, the European Society for Paediatric Gastroenterology
and Nutrition recommended that the protein-to-energy ratio for pre-
term infant formula should be 3.2 to 4.1 g/100 kcal [14]. The goal in
estimating the protein nutritional needs of the preterm infant is to
provide the quantity and quality of protein needed to achieve fetal
rates of tissue growth and to avoid accumulation of potentially harm-
ful protein metabolic products [15].
Besides gestational age, birth weight is also an important biological
condition that may influence infant neurodevelopment. A recent
study has shown that among preterm infants, low-birth-weight infants
who are extremely pretermmay be themost at risk for nutritive feeding
maturation problems compared with less preterm infants [16]. On the
one hand, vigorous feeding in low-birth-weight infants in order to ac-
celerate growth and improve nutritional status could help reduce infant
morbidity andmortality. However, recent studies suggest that catch-up
growth and rapid postnatal weight gain may be associated with the de-
velopment of chronic adult diseases, such as obesity, cardiovascular dis-
ease, and type 2 diabetes [17]. Strategies to modify accelerated growth
will need to evaluate the benefits of improved nutritional status and the
potential costs of future chronic disease [18].
3. Ghrelin
Ghrelin is a 28-amino-acid peptide hormone first described in
1999 as the endogenous ligand for the growth hormone secretagogue
receptor (GHS-R). Ghrelin is predominantly produced in the oxyntic
mucosa of the stomach by enteroendocrine X/A-like cells, and lower
amounts are derived from the bowel, pancreas, kidneys, immune sys-
tem, placenta, testes, pituitary, lung, and hypothalamus [19]. In mam-
mals, ghrelin is derived from a 117-amino-acid polypeptide termed
pro-ghrelin, following cleavage after the 28th amino acid residue by
prohormone convertase 1 [20]. It circulates in the bloodstream,
bound to lipoproteins [21]. A portion of ghrelin has a fatty acid mod-
ification, an n-octanoylation, attached to the serine at position 3. This
form, known as acylated or active ghrelin, accounts for only 5–10% of
the total circulating ghrelin, and is thought to be essential for binding
to the GHS-R-1a. More than 90% of ghrelin immunoreactivity in
human plasma consists of the unacylated portion, also called des-
acyl-ghrelin, which results from ghrelin deacylation by butyrylcholi-
nesterase and platelet-activating factor acetylhydrolase [22].
Besides the stimulation of growth hormone (GH) release from the
pituitary [23], ghrelin has a broad spectrum of biological functions
which includes stimulation of appetite and a positive energy balance,
control of gastrointestinal motility and gastric acid secretion, modula-
tion of endocrine and exocrine pancreatic secretions, cell prolifera-
tion, glucose and lipid metabolism, and action in cardiovascular and
immunological processes [24].
3.1. Ghrelin's role in energy homeostasis
The regulation of appetite and food intake represents one of themost
important ghrelin actions. Ghrelin administration increases appetite andaviour in preterm infants, Early Hum Dev (2012), doi:10.1016/
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ghrelin into circulation increases prior to feeding, and decreases post-
prandially, suggesting a role of ghrelin in meal initiation [26].
Ghrelin stimulates appetite by acting on the hypothalamic arcuate
nucleus, a region known to control food intake (Fig. 1). Ghrelin-
induced feeding results from the activation of the orexigenic neu-
rones expressing neuropeptide Y (NPY) and agouti-related protein
(AgRP) in the hypothalamic arcuate nucleus [27]. Ghrelin also inhibits
anorexigenic neurones expressing pro-opiomelanocortin, preventing
the release of α-melanocyte-stimulating hormone and activates neu-
rones expressing orexin in the lateral hypothalamic area [28].
In NPY/AgRP cells in the hypothalamic arcuate nucleus, ghrelin
stimulates adenosine monophosphate-activated protein kinase
(AMPK) and regulates fatty acid metabolism. In fact, through its bind-
ing to the GHS-R, ghrelin increases intracellular calcium, which in-
duces the phosphorylation of AMPK. Phosphorylated AMPK, through
the phosphorylation of the acetyl-coenzyme A carboxylase, inhibits
the formation of malonyl-coenzyme A and consequently activates
carnitine palmitoyltransferase-1. Mitochondrial β-oxidation is in-
creased, reactive oxygen species (ROS) are generated and uncoupling
protein-2 is stimulated, which promotes ROS scavenging and stimu-
lates NPY/AgRP transcription [29].
In addition to playing a role in the control of food intake by orexigenic
and anorexigenic pathways, ghrelin may stimulate appetite through the
vagus nerve by mediating the signal from the gut to the brain [29].
Recent studies have suggested that, besides stimulating appetite
by hypothalamic circuits, ghrelin is involved in the regulation of feed-
ing behaviour, acting on two dopaminergic regions of the mesolimbic
system, the striatum and ventral tegmental area (VTA). Administra-
tion of ghrelin into the VTA increases food intake and stimulates do-
pamine release from the VTA [30]. Ghrelin also stimulates brain
activity in the amygdala, orbitofrontal cortex, anterior insula, and stri-
atum, which are involved in the control of appetitive behaviour [31].Fig. 1. Hormones that control eating: ghrelin stimulates appetite by activating the NPY/AgR
neuropeptide Y; AgRP, agouti-related protein.
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in the short-term orexigenic action, but also in the long-term regula-
tion of body weight [32]. Ghrelin induces body weight gain and adi-
posity by stimulating food intake, with a preference for fat
ingestion, promoting fat storage, reducing energy expenditure and
fat utilization, and increasing carbohydrate utilization [33]. Plasma
ghrelin levels are negatively correlated with body mass index. Indeed,
patients with obesity and anorexia have, respectively, lower and higher
plasma ghrelin levels than healthy subjects with normal body weight
[34]. Ghrelin level variates in a compensatory manner to body-weight
variations: ghrelin secretion is increased in response to weight loss in-
duced by food restriction and long-term exercise, while it decreases
under positive energy-balance conditions, such asweight gain resulting
from overfeeding, pregnancy, and high-fat diet [35].
Ghrelin has been also reported to play a role in glucose homeosta-
sis. In humans, peripheral injection of ghrelin is followed by an in-
crease in glycaemia, that is then followed by a transient decrease in
circulating insulin levels, probably through a direct GH-independent
glycogenolytic effect [36]. Also, ghrelin secretion seems to be sup-
pressed, at least in part, by increased plasma glucose level as well as
by insulin [37].3.2. Ghrelin in fetus, term and preterm neonates
Ghrelin levels vary from fetal life through to early adulthood rang-
ing from 200 to 800 pg/ml, with the highest levels observed in the
first years of life [38]. Ghrelin has been detected in human cord
blood as early as 22 weeks of gestation, suggesting a possible role of
ghrelin during intrauterine life [39]. The source of ghrelin in fetal
life is not well defined as it seems to be produced by fetal tissues
[40], even though it may also originate from the maternal compart-
ment or may be secreted by the placenta [41]. ImmunoreactiveP-expressing neurones. [Modified by Schwartz MW and Morton GJ. Nature 2002.]NPY,
aviour in preterm infants, Early Hum Dev (2012), doi:10.1016/
4 F. Savino et al. / Early Human Development xxx (2012) xxx–xxxghrelin cells have been observed in fetal stomach, duodenum, pancre-
as, and lung from the 10th week of gestation [42].
Some studies have shown that circulating ghrelin levels remain rela-
tively constant throughout the gestation andat birth,with no differences
in cord ghrelin levels between term and preterm newborns [43,44].
However, another study reported that cord ghrelin levels are higher in
term than in preterm neonates (median [25th–75th percentile] 399.0
[229.0–438.0] pg/ml versus 208.0 [144.5–278.9] pg/ml, respectively)
[45]. The same discrepancy regards the correlation between ghrelin
levels and neonatal anthropometric parameters, as in term infants, plas-
ma ghrelin was inversely associated with birth weight and length [46],
while another study reported that ghrelin levels did not correlate signif-
icantly with anthropometric parameters in newborns [47].
Moreover, it is not well defined how ghrelin acts in energy ho-
meostasis and metabolism during fetal and neonatal life. In a study
conducted on premature infants with a gestational age ranging from
25 to 35 weeks, cord blood acylated and total ghrelin did not correlate
with GH concentration, suggesting that ghrelin probably is not re-
sponsible for the high GH concentrations observed during gestation
[48]. In the same study, cord blood ghrelin correlated positively
with maternal ghrelin and negatively with neonatal glucose levels.
Total ghrelin concentration in cord blood of SGA infants was signifi-
cantly higher than in AGA infants [49]. Higher cord blood ghrelin
levels have been also detected in preterm SGA newborns than in
AGA ones [39] and in newborns with IUGR [50]. It has been suggested
that, in these infants, higher ghrelin levels could play a role in fetal
adaptation to intrauterine malnutrition, stimulate appetite, and result
in higher nutritional intake by the neonate, contributing to catch-up
growth [51]. The same observation emerges from another study in
which it has been reported that, in the first days of life, ghrelin secre-
tion is refractory to the effect of feeding, and increased ghrelin levels
may act as an anabolic drive to promote food intake [52]. Moreover,
low cord ghrelin concentrations have been associated with slow
weight gain in the first 3 months of life [53], supporting that this hor-
mone may regulate feeding behaviour in early life and promote
growth. In a study evaluating serum ghrelin levels of preterm infants
in the early neonatal period, it has been observed that hormone levels
are influenced by the beginning of the enteral feeding, supporting the
hypothesis that the functional profile of the ghrelin system in early
life is orientated to anabolic purposes [54] .
Higher ghrelin levels during the neonatal period could also influ-
ence hormone levels later in life. In fact, it has been observed that in-
creased ghrelin levels in preterm born children in the early neonatal
period are sustained up to prepubertal ages.
Two possible explanations may be proposed to explain the reason
why ghrelin is significantly higher in preterm than in full-term neo-
nates: the first one is that its synthesis or secretion could be increased;
and the second one is a possible reduction in the ghrelin clearance rate.
Evidence exists that the kidney is the primary site of ghrelin clearance,
while the liver plays aminor part. It is possible that the elevated ghrelin
level in the peripheral blood of preterm infants may result from the de-
crease in the clearance rate because the two main clearance sites of
ghrelin are not fully mature in preterm infants.
3.3. Ghrelin in infants
Studies on serum ghrelin levels in infants are scanty. Ghrelin levels
increase after birth, peaking during the first 2 years of life [38]. We
have conducted a study on infants in the first 4 months of life, showing
that the kind of early feeding could influence ghrelin levels: in fact, FF
infants seem to have higher serum ghrelin levels compared with BF in-
fants [55]. In a cohort of infants aged up to 18 months, serum ghrelin
correlated positively with fasting time and a negative influence of insu-
lin on ghrelin levels was observed [56]. A positive correlation between
circulating ghrelin levels and fasting time was also observed in exclu-
sively FF infants in the first 6 months of life, suggesting that ghrelinPlease cite this article as: Savino F, et al, Ghrelin and feeding beh
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[57]. The negative relationship described between total ghrelin levels
and weight gain during the first year of life may also indicate that ghre-
lin reflects changes in weight beyond the neonatal period [58].
A different feeding behaviour has been described in BF and FF in-
fants [59], and this could be related to differences in ghrelin levels be-
tween the two groups of infants. Recently, it has been observed that
the proportion of infants completely emptying their bottle or cup of
milk during the second half-year of infancy differs according to feed-
ing mode during the first months of life, with the highest percentage
observed in infants only bottle fed (68% versus 27% of infants only fed
at the breast and 54% of infants fed both at the breast and by bottle)
[60]. Considering that ghrelin plays an important role in food intake
regulation, different hormone levels in early life could influence feed-
ing behaviour both in the short- and long-term.
3.4. Ghrelin in breast milk
Ghrelin has been detected in both term and preterm human BM
with similar concentrations and higher than those typically found in
plasma; moreover it has been observed that its levels are higher in
whole milk than in skimmed milk [61]. Ghrelin concentration has
been evaluated in colostrum (70.3±18 pg/ml), transitional milk
(83.8±18 pg/ml) and mature milk (97.3±13 pg/ml), showing
lower levels than those typically found in plasma [62]. Also, acylated
ghrelin has been reported in BM, showing that its concentrations in-
crease during lactation and are significantly related to serum ghrelin
concentrations in BF infants; active and total ghrelin concentrations
in BM were lowest at 0–3 days, whereas they increased progressively
during 180 days of the lactation period [63].
4. Concluding remarks
Early nutrition could influence the programming of metabolic de-
velopment and growth, exerting both short- and long-term effects,
and particularly, this could be a time when dietary practices are
established and will continue throughout childhood. Food prefer-
ences are shaped by a combination of genetic and environmental fac-
tors, a better understanding of which is critical to the development of
effective dietary interventions.
Providing appropriate nutrition is a cornerstone of the care of pre-
term infants and it represents a challenge for paediatricians. Path-
ways involved in appetite regulation and feeding behaviour mature
early in postnatal life. Among the biological factors involved in the de-
velopment of these mechanisms, ghrelin plays a key role. The pres-
ence of ghrelin in cord blood as early as 23 weeks of gestation
suggests a role for this peptide in the developing fetus, possibly as a
promoting factor for fetal growth. During the later stages of gestation,
ghrelin may acquire its metabolic role inducing adiposity, stimulating
appetite, and regulating glucose homeostasis. Preterm infants may
have an immaturity in energy-balance regulation that also involves
neuronal pathways that mediate the effects of ghrelin. Moreover,
ghrelin could represent a marker for altered metabolism in infants'
IUGR. In fact, higher cord blood ghrelin levels in term and preterm
SGA newborns and in newborns with IUGR suggest that ghrelin
could play a role in fetal adaptation to intrauterine malnutrition and
contribute to catch-up growth in these neonates. Considering that
early life nutrition and growth could programme the set-point of en-
ergy homeostasis later in life, investigation of the possible actions of
ghrelin in fetal and neonatal life can contribute to the understanding
of its role in feeding behaviour in infancy.
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